Viewing Study NCT03960502


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-03-22 @ 4:43 PM
Study NCT ID: NCT03960502
Status: COMPLETED
Last Update Posted: 2019-10-23
First Post: 2019-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881
Sponsor: Agios Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AG881-C-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators